FDA Approved Products

4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Active:Lifecycle: LOE ApproachingClear all
DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
the treatment of chronic kidney failure in patients being maintained on peritoneal dialysischronic kidney failure
1984
NDA
30/100
DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER
dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
the treatment of chronic kidney failure in patients being maintained on peritoneal dialysischronic kidney failure
1984
NDA
30/100
DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER
dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
the treatment of chronic kidney failure patients being maintained on peritoneal dialysis For treatment of chronic kidney failure
1992
NDA
30/100
DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
1980
NDA
30/100
DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
the treatment of chronic kidney failure in patients being maintained on peritoneal dialysischronic kidney failure
1984
NDA
30/100
DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER
dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
the treatment of chronic kidney failure in patients being maintained on peritoneal dialysischronic kidney failure
1984
NDA
30/100
DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER
dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
the treatment of chronic kidney failure patients being maintained on peritoneal dialysis For treatment of chronic kidney failure
1992
NDA
30/100
DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
1980
NDA
30/100
DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
the treatment of chronic kidney failure in patients being maintained on peritoneal dialysischronic kidney failure
1984
NDA
30/100
DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
1980
NDA
30/100
DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER
dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
the treatment of chronic kidney failure in patients being maintained on peritoneal dialysischronic kidney failure
1984
NDA
30/100
DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER
dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
the treatment of chronic kidney failure patients being maintained on peritoneal dialysis For treatment of chronic kidney failure
1992
NDA
30/100
DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
1980
NDA
30/100
DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
1980
NDA
30/100
DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
1980
NDA
30/100
DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
1980
NDA
30/100
DELSYM
dextromethorphan
LOE Approaching
ORAL · SUSPENSION, EXTENDED RELEASE
cough due to minor throatbronchial irritation+1
1982
NDA
30/100
DELTA-CORTEF
prednisolone
LOE Approaching
Pfizer
ORAL · TABLET
the following conditions: 1systemic lupus erythematosus+15
1955
NDA
30/100
DELTASONE
prednisone
LOE Approaching
Pfizer
ORAL · TABLET
the following conditions: Endocrine Disorders Primarysecondary adrenocortical insufficiency (hydrocortisone+9
1955
NDA
30/100
DEMADEX
torsemide
LOE Approaching
Roche
INTRAVENOUS · SOLUTION
edema associated with congestive heart failurerenal disease+5
1993
NDA
30/100
DEMADEX
torsemide
LOE Approaching
ORAL · TABLET
edema associated with congestive heart failurerenal disease+5
1993
NDA
30/100
DEMEROL
meperidine hydrochloride
LOE Approaching
ORAL · TABLET
pain severe enough to require an opioid analgesicfor which alternative treatments are inadequate
1942
NDA
30/100
DEMEROL
meperidine hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
pain severe enough to require an opioid analgesicfor which alternative treatments are inadequate
1942
NDA
30/100
DEMI-REGROTON
chlorthalidone; reserpine
LOE Approaching
Sanofi
ORAL · TABLET
the management of hypertension eitherto enhance the effect of other antihypertensive drugs in the more severe forms of hypertension+7
1964
NDA
30/100
← PreviousPage 42 of 188Next →